发明名称 |
Reduction in myocardial infarction size |
摘要 |
This invention provides methods and compositions used for reducing the Myocaidial Infarct (MI) size in diabetic subjects exhibiting the haptoglobin (Hp) 2 allele. Specifically, the invention relates to reduction of MI in diabetic subjects carrying the Hp-2 allele by reducing the oxidative sterss in these subjects following ischemia-reperfusion injury.
|
申请公布号 |
US2007014764(A1) |
申请公布日期 |
2007.01.18 |
申请号 |
US20050183251 |
申请日期 |
2005.07.18 |
申请人 |
LEVY ANDREW;BERKOWITZ NOAH |
发明人 |
LEVY ANDREW;BERKOWITZ NOAH |
分类号 |
A61K38/20;A61K38/17;A61K38/44 |
主分类号 |
A61K38/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|